Clinical trials
Completed Phase 4 Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 2 |
| AstraZeneca | 1 |
| Celgene | 1 |
| Cytori Therapeutics | 1 |
| Jemincare | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| Novartis Pharmaceuticals | 1 |
| Sirtex Medical | 1 |
| VA Office of Research and Development | 1 |
| Xoft, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 11 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Neoplasms | 3 |
| Basal Cell Carcinoma | 2 |
| Breast Neoplasms | 2 |
| Carcinoma, Squamous Cell | 2 |
| Lung Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Adenoma | 1 |
| Brain Neoplasms | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.